Kae Hashimoto

2.7k total citations
73 papers, 2.1k citations indexed

About

Kae Hashimoto is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kae Hashimoto has authored 73 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 24 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Kae Hashimoto's work include Ovarian cancer diagnosis and treatment (13 papers), MicroRNA in disease regulation (12 papers) and Circular RNAs in diseases (9 papers). Kae Hashimoto is often cited by papers focused on Ovarian cancer diagnosis and treatment (13 papers), MicroRNA in disease regulation (12 papers) and Circular RNAs in diseases (9 papers). Kae Hashimoto collaborates with scholars based in Japan, United States and Canada. Kae Hashimoto's co-authors include Kenjiro Sawada, Seiji Mabuchi, Tadashi Kimura, Yasuto Kinose, Michiko Kodama, Koji Nakamura, Tadashi Kimura, Erika Nakatsuka, Mahiru Kawano and Hirohisa Kurachi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer.

In The Last Decade

Kae Hashimoto

72 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kae Hashimoto Japan	27	1.2k	781	632	518	232	73	2.1k
Sunila Pradeep United States	26	1.1k 0.9×	622 0.8×	499 0.8×	361 0.7×	167 0.7×	64	1.9k
Adele Marrangoni United States	22	855 0.7×	354 0.5×	861 1.4×	465 0.9×	363 1.6×	28	2.0k
Cecilia S. Leung United States	11	1.2k 1.0×	824 1.1×	450 0.7×	253 0.5×	242 1.0×	17	1.7k
Bin Shi China	10	1.2k 1.0×	606 0.8×	852 1.3×	219 0.4×	107 0.5×	16	2.1k
Stefania Canè Italy	23	619 0.5×	310 0.4×	698 1.1×	768 1.5×	125 0.5×	39	2.0k
Hee Jung An South Korea	27	1.3k 1.0×	766 1.0×	818 1.3×	286 0.6×	181 0.8×	76	2.5k
Heini Lassus Finland	25	1.0k 0.9×	555 0.7×	830 1.3×	184 0.4×	487 2.1×	44	2.0k
Lalit R. Patel United States	18	941 0.8×	660 0.8×	1.1k 1.8×	451 0.9×	68 0.3×	26	2.3k
Sanaz Memarzadeh United States	23	1.1k 0.9×	424 0.5×	918 1.5×	345 0.7×	509 2.2×	60	2.3k
P Wülfing Germany	22	773 0.6×	452 0.6×	576 0.9×	194 0.4×	108 0.5×	47	1.7k

Countries citing papers authored by Kae Hashimoto

Since Specialization

Citations

This map shows the geographic impact of Kae Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kae Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kae Hashimoto more than expected).

Fields of papers citing papers by Kae Hashimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kae Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kae Hashimoto. The network helps show where Kae Hashimoto may publish in the future.

Co-authorship network of co-authors of Kae Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Kae Hashimoto. A scholar is included among the top collaborators of Kae Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kae Hashimoto. Kae Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kinose, Yasuto, Koji Nakamura, Aska Toda, et al.. (2025). PI3K/mTOR Dual Inhibitor GSK458 and Arsenic Trioxide Exert Synergistic Antitumor Effects against Ovarian Clear-Cell Carcinoma. Molecular Cancer Therapeutics. 24(4). 563–575. 1 indexed citations

Sawada, Kenjiro, Mayuko Miyamoto, Aska Toda, et al.. (2023). Continuous Administration of Anti-VEGFA Antibody Upregulates PAI-1 Secretion from Ovarian Cancer Cells via miR-143-3p Downregulation. Molecular Cancer Research. 21(10). 1093–1106. 9 indexed citations

Kodama, Michiko, Jean C. Tien, Justin Y. Newberg, et al.. (2021). Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma. Cancer Research. 81(21). 5413–5424. 7 indexed citations

Shimizu, Aasa, Kenjiro Sawada, Masaki Kobayashi, et al.. (2021). Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer. Molecular Cancer Research. 19(9). 1583–1595. 66 indexed citations

Kodama, Michiko, Toru Okamoto, Makoto Tokunaga, et al.. (2021). Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1. Biochemical and Biophysical Research Communications. 552. 120–127. 22 indexed citations

Komura, Naoko, Seiji Mabuchi, Kotaro Shimura, et al.. (2020). The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer. Cancer Immunology Immunotherapy. 69(12). 2477–2499. 86 indexed citations

Kobayashi, Eiji, Michiko Kodama, Kae Hashimoto, et al.. (2020). Oncological and Reproductive Outcomes of Abdominal Radical Trachelectomy. Anticancer Research. 40(10). 5939–5947. 5 indexed citations

Sasano, Tomoyuki, Seiji Mabuchi, Katsumi Kozasa, et al.. (2018). The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations. Clinical Cancer Research. 24(16). 4018–4029. 40 indexed citations

Yokoi, Eriko, Seiji Mabuchi, Kotaro Shimura, et al.. (2018). Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer. Investigational New Drugs. 37(5). 818–827. 20 indexed citations

10.

Komura, Naoko, Eriko Yokoi, Katsumi Kozasa, et al.. (2017). Prognostic significance of pretreatment leukocyte alterations in patients with epithelial ovarian cancer. 69(2). 538. 1 indexed citations

11.

Nakamura, Koji, Kenjiro Sawada, Yasuto Kinose, et al.. (2016). Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells. Molecular Cancer Research. 15(1). 78–92. 183 indexed citations

12.

Toda, Aska, Kenjiro Sawada, Koji Nakamura, et al.. (2016). Targeting Inhibitor of κB Kinase β Prevents Inflammation-Induced Preterm Delivery by Inhibiting IL-6 Production from Amniotic Cells. American Journal Of Pathology. 186(3). 616–629. 13 indexed citations

13.

Kinose, Yasuto, Kenjiro Sawada, Hiroshi Makino, et al.. (2015). IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment. Molecular Cancer Therapeutics. 14(4). 909–919. 23 indexed citations

14.

Kawano, Mahiru, Seiji Mabuchi, Yuri Matsumoto, et al.. (2015). The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer. Scientific Reports. 5(1). 18217–18217. 124 indexed citations

15.

Sawada, Kenjiro, Shoji Kamiura, Yasuhiko Tomita, et al.. (2013). miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression. American Journal Of Pathology. 182(5). 1876–1889. 84 indexed citations

16.

Francia, Giulio, Yuval Shaked, Kae Hashimoto, et al.. (2011). Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis. Molecular Cancer Therapeutics. 11(3). 680–689. 33 indexed citations

17.

Ogata, Seiji, Ken‐ichirou Morishige, Kenjiro Sawada, et al.. (2009). Fasudil Inhibits Lysophosphatidic Acid-Induced Invasiveness of Human Ovarian Cancer Cells. International Journal of Gynecological Cancer. 19(9). 1473–1480. 40 indexed citations

18.

Shimizu, Shoko, Masahiro Tahara, Seiji Ogata, et al.. (2007). Involvement of nuclear factor-kB activation through RhoA/Rho-kinase pathway in LPS-induced IL-8 production in human cervical stromal cells. Molecular Human Reproduction. 13(3). 181–187*. 54 indexed citations

19.

Shimoya, Koichiro, Kae Hashimoto, Akihiro Moriyama, et al.. (1999). Endometrial Development Was Improved by Transdermal Estradiol in Patients Treated with Clomiphene Citrate. Gynecologic and Obstetric Investigation. 47(4). 251–254. 15 indexed citations

20.

Hashimoto, Kae. (1974). Ultrastructure of freeze-cleaved dermal collagen. Acta Dermato Venereologica. 54(4). 241–248. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact